MEMBER'S LOGINX
| Invalid Username / Password | ||||||||
| Invalid Captcha | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
India's Third Giant Leap
This Could be One of the Biggest Opportunities for Investors
- Home
- Stock Quote
- Sector Info (List of bse healthcare Stocks)
- List of BSE Healthcare Stocks
List of BSE Healthcare
Stocks 
Here are the latest stock price details of the stocks in the BSE Healthcare. For more detailed updates, check the latest BSE Healthcare stock results and see the latest BSE Healthcare long term chart.
| SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
|---|---|---|---|---|
| AARTI DRUGS | 449.00 -1.48% | 449.25 -1.21% |
|
More Info
|
| ABBOTT INDIA | 27,699.70 2.04% | 27,718.50 2.23% |
|
More Info
|
| AJANTA PHARMA | 2,960.30 0.33% | 2,960.05 0.49% |
|
More Info
|
| ALEMBIC | 124.15 0.57% | 124.11 0.69% |
|
More Info
|
| ALEMBIC PHARMA | 1,041.80 0.35% | 1,041.85 0.39% |
|
More Info
|
| ALKEM LABORATORIES | 5,571.95 -0.55% | 5,583.35 -0.38% |
|
More Info
|
| APOLLO HOSPITALS | 6,932.35 2.80% | 6,935.10 2.86% |
|
More Info
|
| ASTER DM HEALTHCARE | 432.35 1.36% | 432.30 0.97% |
|
More Info
|
| ASTRAZENECA PHARMA | 6,336.90 0.76% | 6,319.85 0.23% |
|
More Info
|
| AUROBINDO PHARMA | 1,223.65 0.28% | 1,223.70 0.30% |
|
More Info
|
| BIOCON | 331.20 2.49% | 331.50 2.60% |
|
More Info
|
| CAPLIN POINT | 1,964.95 1.10% | Not Listed |
|
More Info
|
| CIPLA | 1,486.30 1.41% | 1,486.50 1.43% |
|
More Info
|
| DISHMAN CARBOGEN AMCIS | 228.55 4.77% | 228.44 4.54% |
|
More Info
|
| DIVIS LABORATORIES | 5,999.40 0.40% | 5,998.35 0.36% |
|
More Info
|
| DR. LAL PATHLABS | 3,057.75 0.97% | 3,053.65 0.91% |
|
More Info
|
| DR. REDDYS LAB | 1,213.90 1.62% | 1,214.45 1.60% |
|
More Info
|
| ERIS LIFESCIENCES | 1,376.15 0.75% | 1,374.20 0.53% |
|
More Info
|
| FDC | 488.90 1.00% | 488.05 0.53% |
|
More Info
|
| FORTIS HEALTHCARE | 686.80 0.92% | 685.85 0.76% |
|
More Info
|
| GLAND PHARMA | 1,756.55 -1.79% | 1,755.05 -1.79% |
|
More Info
|
| GLENMARK PHARMA | 1,480.05 1.01% | 1,478.20 0.80% |
|
More Info
|
| GRANULES INDIA | 558.90 2.47% | 559.50 2.69% |
|
More Info
|
| GSK PHARMA | 2,415.20 1.86% | 2,411.80 1.78% |
|
More Info
|
| GUFIC BIOSCIENCE | 403.15 -1.15% | 403.95 -0.41% |
|
More Info
|
| GUJ.THEMIS. | 311.95 -1.89% | Not Listed |
|
More Info
|
| HEALTHCARE GLOBAL ENTER. | 468.75 0.07% | 468.30 -0.04% |
|
More Info
|
| HESTER BIOSCIENCES | 2,379.15 0.06% | 2,385.45 0.15% |
|
More Info
|
| HIKAL. | 390.75 0.80% | 391.05 1.12% |
|
More Info
|
| INDOCO REMEDIES | 320.00 6.72% | 320.05 6.75% |
|
More Info
|
| INDRAPRASTHA MEDICAL | 418.20 0.59% | 419.15 0.78% |
|
More Info
|
| IOL CHEMICALS & PHARM. | 348.15 2.01% | 348.20 1.89% |
|
More Info
|
| IPCA LABS | 1,590.55 1.10% | 1,591.35 1.13% |
|
More Info
|
| J.B.CHEMICALS | 1,734.20 1.12% | 1,743.40 2.43% |
|
More Info
|
| JUBILANT PHARMOVA | 1,141.20 0.92% | 1,138.50 0.72% |
|
More Info
|
| KIMS | 595.30 1.80% | 595.25 1.93% |
|
More Info
|
| KOVAI MEDICAL | 5,236.00 -0.71% | 2,576.65 -2.28% |
|
More Info
|
| LAURUS LABS | 512.45 4.78% | 512.60 4.79% |
|
More Info
|
| LUPIN | 2,069.95 1.30% | 2,071.35 1.39% |
|
More Info
|
| MARKSANS PHARMA. | 308.55 -0.15% | 308.65 -0.16% |
|
More Info
|
| MAX HEALTHCARE INSTITUTE | 999.80 1.03% | 999.95 0.99% |
|
More Info
|
| METROPOLIS HEALTHCARE | 2,062.10 2.28% | 2,061.85 2.29% |
|
More Info
|
| MOREPEN LABS | 74.05 1.15% | 73.93 0.96% |
|
More Info
|
| NARAYANA HRUDAYALAYA | 1,271.85 1.02% | 1,272.20 1.05% |
|
More Info
|
| NATCO PHARMA | 1,356.00 -1.35% | 1,357.60 -1.25% |
|
More Info
|
| NEULAND LABS | 14,904.25 0.75% | 14,904.95 0.93% |
|
More Info
|
| NIFTY 50 | Not Listed | 23,907.25 2.39% |
|
More Info
|
| NOVARTIS | 1,025.80 0.14% | Not Listed |
|
More Info
|
| PANACEA BIOTECH | 409.45 -1.28% | 410.00 -0.97% |
|
More Info
|
| PFIZER | 5,222.05 1.81% | 5,225.65 1.84% |
|
More Info
|
| POLY MEDICURE | 2,581.85 -0.29% | 2,582.15 -0.27% |
|
More Info
|
| PROCTER & GAMBLE HEALTH | 5,092.55 -0.62% | 5,094.80 -0.48% |
|
More Info
|
| RPG LIFE SCIENCES | 1,986.05 -2.41% | 1,991.95 -1.98% |
|
More Info
|
| S&P BSE HEALTHCARE | 42,969.55 1.23% | Not Listed |
|
More Info
|
| S&P BSE SENSEX | 79,117.11 2.54% | Not Listed |
|
More Info
|
| SANOFI INDIA | 6,052.95 -0.46% | 6,054.05 -0.37% |
|
More Info
|
| SEQUENT SCIENTIFIC | 201.70 5.00% | 202.09 4.94% |
|
More Info
|
| SHALBY | 215.55 0.21% | 215.33 -0.19% |
|
More Info
|
| SHILPA MEDICARE | 911.00 -2.65% | 912.80 -2.48% |
|
More Info
|
| SMS PHARMA | 241.25 0.63% | 241.15 0.77% |
|
More Info
|
| SOLARA ACTIVE PHARMA SCIENCES | 798.40 4.88% | 799.50 5.00% |
|
More Info
|
| STRIDES PHARMA SCIENCE | 1,503.75 0.04% | 1,504.25 0.04% |
|
More Info
|
| SUN PHARMA | 1,797.80 1.13% | 1,795.30 0.86% |
|
More Info
|
| SUN PHARMA ADV. RES. | 204.40 7.35% | 204.50 7.44% |
|
More Info
|
| SUVEN LIFE SCIENCES | 117.45 -0.59% | 117.47 -0.53% |
|
More Info
|
| SUVEN PHARMACEUTICALS | 1,294.35 1.41% | 1,295.15 1.62% |
|
More Info
|
| SYNCOM FORMULATIONS | 19.51 -1.06% | Not Listed |
|
More Info
|
| SYNGENE INTERNATIONAL | 869.40 2.58% | 869.30 2.64% |
|
More Info
|
| THEMIS MEDICARE | 289.50 0.66% | 289.45 0.61% |
|
More Info
|
| THYROCARE TECHNOLOGIES | 957.45 -1.33% | 956.15 -1.40% |
|
More Info
|
| TORRENT PHARMA | 3,170.55 2.13% | 3,167.10 2.10% |
|
More Info
|
| TTK HEALTHCARE | 1,506.80 4.25% | 1,496.75 3.34% |
|
More Info
|
| UNICHEM LAB | 856.10 -0.52% | 857.95 -0.30% |
|
More Info
|
| VIMTA LABS | 760.80 -0.59% | 763.70 -0.12% |
|
More Info
|
| WOCKHARDT | 1,230.95 5.00% | 1,233.40 5.00% |
|
More Info
|
| ZYDUS LIFESCIENCES | 948.70 0.47% | 948.90 0.51% |
|
More Info
|
BSE prices: November 22, 2024 (Close) NSE prices: November 22, 2024 (Close)
BSE Healthcare Stocks Update
The S&P BSE HEALTHCARE Index was at 42,969.6 (up 1.2%). The index is down 2.0% over the last 30 days. And over the last 1 year, it has gained 44.4%.
Within the BSE Healthcare Index, the top gainers were KOPRAN. (up 10.0%) and SUN PHARMA ADV. RES. (up 7.4%). On the other hand, SHILPA MEDICARE (down 2.7%) and VENUS REMEDIES (down 2.6%) were among the top losers.
Meanwhile, the benchmark S&P BSE SENSEX was at 79,117.1 (up 2.5%).
Before you go, here are the upcoming corporate actions for BSE Healthcare stocks.
Upcoming Dividends
| COMPANY | PRICE (Rs) | CHANGE (%) | DIVIDEND (%) | RECORD DATE | EX-DIVIDEND DATE |
|---|---|---|---|---|---|
| IPCA LABS | 1,590.55 | 1.10 | 200.0 | 27-Nov-24 | 27-Nov-24 |
| NATCO PHARMA | 1,356.00 | -1.35 | 75.0 | 27-Nov-24 | 27-Nov-24 |
| PROCTER & GAMBLE HEALTH | 5,092.55 | -0.62 | 600.0 | 29-Nov-24 | 28-Nov-24 |
List of All Upcoming Dividends
FAQs
What is BSE Healthcare Index?
The BSE healthcare index comprises constituents of the BSE 500 index that are classified under the healthcare sector.
The index is calculated using a float-adjusted market cap weighted methodology.
To filter the best quality stocks from the BSE healthcare index, check out Equitymaster’s Indian stock screener. This screener also allows you to screen stocks based on your own criteria.
Also take a look at our detailed analysis of the best pharma and healthcare stocks in India.
Which are the top BSE healthcare companies?
Based on marketcap, these are the top 5 companies in the BSE healthcare index:
You can see the full list of the BSE healthcare stocks here.
And for a fundamental analysis of the above companies, check out Equitymaster’s Indian stock screener which has a separate screen for top healthcare companies in India.
What is the price of BSE healthcare index live today?
The S&P BSE HEALTHCARE last traded at 42,969.6. It was up 1.2% over its previous close.
Within the BSE Healthcare Index, the top gainers were KOPRAN. (up 10.0%) and SUN PHARMA ADV. RES. (up 7.4%). On the other hand, SHILPA MEDICARE (down 2.7%) and VENUS REMEDIES (down 2.6%) were among the top losers.
For more, please visit the BSE healthcare index live chart and also check out our pharma sector report.
Can we buy the BSE healthcare index?
The BSE healthcare index is a collection of stocks and not a security that is traded on any stock exchange. Hence, we cannot buy it directly.
However, there are ways in which one can invest in the BSE healthcare index.
One can invest in index funds or ETFs representing the index or buying future and options for it.
Which are the other important indices one should track?
Well, it depends on what your goals are.
Having said that, the two key indices to track are the BSE Sensex and the NSE Nifty.
However, these two indices are considered to be too narrow by some, since they only track 30 and 50 stocks, respectively.
For broader tracking, you could use the BSE 200, BSE 500 or even the NSE 500 index.
Some popular market cap based indices include BSE Smallcap index and BSE Midcap index, among others.
Today's Market
![Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising]()
Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks
TRENDING TOPICS
Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407
Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com
LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.